Treatment of actinic keratosis with tirbanibulin in private practice dermatology. Our experience in terms of efficacy and patient perception
to be much/somewhat improved and 92% of physicians and 89% of patients were extremely/very satisfied or satisfied with tirbanibulin to improve "how skin looks" and "skin texture".Moreover, 88% of physicians and 82% of patients reported tirbanibulin to be much/ somewhat better compared with previous topical treatment.87% of physicians and 86% of patients reported likelihood to consider tirbanibulin again, if needed.Figure 2. Clinical clearance at baseline, Day 8 and Day 57 with use of tirbanibulin for actinic keratoses on face: 55 years-old woman with 5 lesions at baseline.No LTS.CC at Day 57.Conclusions: Physicians' and patients' overall satisfaction with tirbanibulin was high, and both reported great likelihood to use tirbanibulin in future.These results are comparable to previous ones [2].
Authors
- Antonio Olveira (ORCID: https://orcid.org/0000-0002-2991-4688)
- Paulo Varela (ORCID: https://orcid.org/0000-0002-0934-1528)
Institutions
- Universidad de Málaga (ES)
Publication Details
- Journal
- EJC Skin Cancer
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ejcskn.2025.100301
- Citations
- 1
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35